purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Exposure Biomarkers
1.2.3 Effect Biomarkers
1.2.4 Susceptibility Biomarkers
1.3 Market by Application
1.3.1 Global Pharmacodynamic (PD) Biomarkers Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmacodynamic (PD) Biomarkers Market Perspective (2017-2028)
2.2 Pharmacodynamic (PD) Biomarkers Growth Trends by Region
2.2.1 Pharmacodynamic (PD) Biomarkers Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmacodynamic (PD) Biomarkers Historic Market Size by Region (2017-2022)
2.2.3 Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Region (2023-2028)
2.3 Pharmacodynamic (PD) Biomarkers Market Dynamics
2.3.1 Pharmacodynamic (PD) Biomarkers Industry Trends
2.3.2 Pharmacodynamic (PD) Biomarkers Market Drivers
2.3.3 Pharmacodynamic (PD) Biomarkers Market Challenges
2.3.4 Pharmacodynamic (PD) Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacodynamic (PD) Biomarkers Players by Revenue
3.1.1 Global Top Pharmacodynamic (PD) Biomarkers Players by Revenue (2017-2022)
3.1.2 Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Players (2017-2022)
3.2 Global Pharmacodynamic (PD) Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacodynamic (PD) Biomarkers Revenue
3.4 Global Pharmacodynamic (PD) Biomarkers Market Concentration Ratio
3.4.1 Global Pharmacodynamic (PD) Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacodynamic (PD) Biomarkers Revenue in 2021
3.5 Pharmacodynamic (PD) Biomarkers Key Players Head office and Area Served
3.6 Key Players Pharmacodynamic (PD) Biomarkers Product Solution and Service
3.7 Date of Enter into Pharmacodynamic (PD) Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacodynamic (PD) Biomarkers Breakdown Data by Type
4.1 Global Pharmacodynamic (PD) Biomarkers Historic Market Size by Type (2017-2022)
4.2 Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Type (2023-2028)
5 Pharmacodynamic (PD) Biomarkers Breakdown Data by Application
5.1 Global Pharmacodynamic (PD) Biomarkers Historic Market Size by Application (2017-2022)
5.2 Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
6.2 North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
6.3 North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
7.2 Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
7.3 Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
8.2 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
8.3 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
9.2 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
9.3 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
10.2 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
10.3 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Introduction
11.1.4 Thermo Fisher Scientific Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Pharmacodynamic (PD) Biomarkers Introduction
11.2.4 Merck Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.2.5 Merck Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Introduction
11.3.4 Bio-Rad Laboratories Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Detail
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Pharmacodynamic (PD) Biomarkers Introduction
11.4.4 QIAGEN Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.4.5 QIAGEN Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Pharmacodynamic (PD) Biomarkers Introduction
11.5.4 Roche Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.5.5 Roche Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Detail
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Pharmacodynamic (PD) Biomarkers Introduction
11.6.4 Danaher Corporation Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.6.5 Danaher Corporation Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Detail
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Pharmacodynamic (PD) Biomarkers Introduction
11.7.4 Siemens Healthcare Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.7.5 Siemens Healthcare Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Pharmacodynamic (PD) Biomarkers Introduction
11.8.4 Abbott Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.8.5 Abbott Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Detail
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Pharmacodynamic (PD) Biomarkers Introduction
11.9.4 Agilent Technologies Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.9.5 Agilent Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details